Summary: Olutamatergic transmission is an important factor in the development of neuronal death following transient cerebral ischemia. In this investigation the ef fects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on neuronal damage were studied in rats exposed to 10 min of transient cerebral ischemia in duced by bilateral common carotid occlusion combined with hypotension. The animals were treated with a blocker of the ionotropic quisqualate or a-amino-3-hydroxy-5-methyl-4-isoxazole (AMPA) receptor, 2.3-dihydroxy-6-nitro-7 -sulfamoyl-benzo(F)q uinoxaline (NBQX), given postischemia as an intraperitoneal bolus dose of 30 mg kg -I followed by an intravenous infusion of 75 Il-g min -I for 6 h, or with the noncompetitive NMDA receptor blocker dizocilpine (MK-801) given 1 mg kg-I i.p. at recirculation and 3 h postischemia, or with the competitive NMDA receptor antagonist DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (COP The synaptic release of the excitatory amino acid glutamate following an ischemic insult is considered to be an important factor in the development of neuronal death. This notion is supported by exper iments where surgical transection of glutamate containing afferents to the hippocampus was per formed, thereby inhibiting glutamatergic neuro transmission and leading to a decrease in ischemic cell damage ipsilateral to the transection (Wieloch et aI., 1985; Onodera et aI., 1986; J�rgensen et aI., Received April 30, 1991; revised June 18, 1991; accepted June 27, 1991. Address correspondence and reprint requests to Dr. B. Nel\gard at Laboratory for Experimental Brain Research, Lund University, Lund Hospital, S-221 85 Lund, Sweden.
The synaptic release of the excitatory amino acid glutamate following an ischemic insult is considered to be an important factor in the development of neuronal death. This notion is supported by exper iments where surgical transection of glutamate containing afferents to the hippocampus was per formed, thereby inhibiting glutamatergic neuro transmission and leading to a decrease in ischemic cell damage ipsilateral to the transection (Wieloch et aI., 1985; Onodera et aI., 1986; J�rgensen et aI., 40116) , 5 mg kg-I, given intraperitoneally at recircula tion. Treatment with NBQX provided a significant reduc tion of neuronal damage in the hippocampal CAl area by 44-69%, with the largest relative decrease in the temporal part of the hippocampus. In neocortex a significant de crease in the number of necrotic neurons was also noted. No protection could be seen following postischemic treat ment with dizocilpine or COP 40116. Our data demon strate that AMPA but not NMDA receptor antagonists decrease neuronal damage following transient severe ce rebral ischemia in the rat and that the protection by NBQX may be dependent on the severity of the ischemic insult. We propose that the AMPA receptor-mediated neurotoxicity could be due to ischemia-induced changes in the control mechanisms of AMPA receptor-coupled processes or to changes of AMP A receptor characteris tics. Key Words: Brain-Glutamate-Ischemia-Neuro nal death-Receptors.
1987). However, it is not fully understood which of the glutamate receptors activate the deleterious in tracellular processes 'leading to cell death. Follow ing the first report on neuronal protection by an N-methyl-o-aspartate (NMDA) receptor antagonist (Simon et aI., 1984) , research has mainly been fo cused on blockade of this receptor complex. In a vast number of investigations, significant neuronal protection by competitive or noncompetitive NMDA receptor antagonists has been achieved in in vitro models of hypoxia, ischemia, and hypogly cemia (Weiss et aI., 1986; Goldberg et aI., 1987; Monyer et aI., 1989) . Furthermore, protection by NMDA antagonists has also been demonstrated in in vivo models of transient cerebral ischemia (Boast et aI., 1988; Gill et aI., 1988; Rod et aI., 1990; Swan and Meldrum, 1990) , focal ischemia (Kochhar et aI., 1988; Park et aI., 1988; Steinberg et aI., 1988) , and hypoglycemic coma (Wieloch, 1985; Westerberg et ai., 1988; Papagapiou and Auer, 1990) . Neuronal protection by NMDA antagonists in models of tran sient severe ischemia has recently been questioned (Fleischer et aI., 1989; Michenfelder et ai., 1989; Sterz et ai., 1989; Lanier et ai., 1990; Buchan et ai., 199 1; Nellgard et aI., 1991) . For example, in a model of cardiac arrest ischemia, dizocilpine, a noncompetitive NMDA antagonist, did not mitigate neuronal damage in the hippocampus (Nellgard et ai., 199 1) despite the protective effects of surgical lesions to the glutamate system in a similar experi mental paradigm (Wieloch et ai., 1985) .
The discovery of a new class of compounds, the quinoxalinediones (Honore et ai., 1988) , that block non-NMDA glutamate receptors, including the ion otropic quisqualate receptor or a-amino-3-hydroxy-5-methyl-4-isoxazole (AMPA) receptor (Watkins and Evans, 198 1) , has greatly facilitated the study of these glutamate receptor subclasses. The quinox alinedione 2.3-dihydroxy-6-nitro-7-sulfamoyl benzo(F) quinoxaline (NBQX) is an AMP A recep tor antagonists that passes the blood-brain barrier (BBB) and diminishes neuronal damage following transient cerebral ischemia in the gerbil (Sheardown et ai., 1990) .
The aim of this study was to investigate and com pare the effects of NMDA and AMP A receptor an tagonists, administered in the postischemic phase, on neuronal damage in the hippocampal CAl region and cerebral neocortex, following 10 min of two vessel occlusion (2-YO) ischemia (Smith et ai., 1984) . The following receptor blockers that pass the BBB were chosen: the noncompetitive NMDA re ceptor antagonist dizocilpine (MK-80 1) (Cline schmidt et al., 1982) , the competitive NMDA recep tor antagonist DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CGP 40116) (Fagg et aI., 1989) , and the AMPA receptor antagonist NBQX (Sheardown et ai., 1990) .
MATERIALS AND METHODS
The surgical procedures were approved by the local ethical committee at Lund University. Male Wistar rats (MjiSllegaard A/S, Denmark), with an average weight of 322 g, were used in this study. Prior to surgery the ani mals were fasted overnight with free access to tap water. Anesthesia was induced by placing the rat in ajar with 3% isoflurane in a mixture of oxygen/nitrous oxide (30:70%). Following intubation with a plastic tube, they were arti ficially ventilated by a rodent respirator (7025 Rodent Ventilator; Ugo Basile Biological Research Appartus, Comeno, Italy). Anesthesia was maintained with 1-2% isoflurane in the oxygen/nitrous oxide (30:70%) gas mix ture. An external jugular vein catheter was then inserted and positioned in the superior caval vein. A tail artery catheter and one vein catheter were also inserted to allow blood sampling, arterial blood pressure recording, and infusions of drugs. The arterial blood pressure was mea sured and recorded continuously until the rats could be extubated. In all animals both common carotid arteries were exposed and encircled by loose ligatures. Arterial blood samples (200 ILl) were collected 15 min prior to ischemia and 15 min postischemia to measure blood gases and blood glucose. If blood gases could not be corrected (Pao2> 90 mm Hg, Paco2 35-45 mm Hg, pH 7.35-7.45) by adjustments of tidal volume or frequency (normally f = 85) of the rodent ventilator, or if the blood glucose was <4 mmol L -I, the rats were excluded from the study. At the end of the surgery bipolar EEG electrodes were in serted into the temporal muscles and the EEG activity was recorded (Mingograf 34, Elema-Schonander, Swe den) every 5-10 min prior to ischemia, continuously dur ing the ischemic insult, and intermittently in the postisch ernie period. These electrodes were removed once post ischemic EEG activity recovered. At the beginning of a 30-min steady-state period prior to induction of ischemia, the inspired isoflurane concentration was decreased to 0.5% and 150 IU kg-I heparin was administered intrave nously. Vecuronium (Organon; Teknika, Boxtel, Hol land), a muscle relaxant, was given as a bolus dose of 0.7 mg followed by an intravenous infusion of 3 mg h -I. At the end of ischemia, both vecuronium and isoflurane were discontinued. The 2-VO ischemia was induced essentially as earlier described (Smith et aI., 1984) . Briefly, blood was withdrawn via the jugular catheter to an MABP of 50 mm Hg and both carotid arteries were clamped. Blood pressure was maintained at 50 mm Hg during the ischemic period by withdrawing or infusing blood through the jug ular catheter. The beginning of the ischemic insult was defined as the time of onset of isoelectric EEG at an MABP of 50 mm Hg. At the end of ischemia, the clamps were removed and the blood reinfused through the jugular catheter, followed by 0.5 ml of 0.6 M sodium bicarbonate. In all experiments, temperature was monitored before, during, and following ischemia (15 min of recovery), us ing thermistors placed in the rectum and subcutaneously under the scalp. Temperature control was accomplished with the aid of a heating lamp and kept at �37°C. Fol lowing the removal of the external jugular vein catheter, all wounds were sutured. Within 45 min after the ischemic inSUlt, the animals resumed adequate spontaneous breathing and the endotracheal tube could thus be re moved. The animals were transferred to a cage where they received supplementary oxygen. If the animals did not eat or drink spontaneously on the day following sur gery, they received a suspension of nutritional fluid, Mer itene (Wander AG, Bern, Switzerland), until they could feed themselves. This was particularly important for the animals treated with CGP 40 116, 5 mg kg -I.
After 1 week of survival the animals were reanesthe tized in a jar with 2% halothane in a gas mixture of oxy gen/nitrous oxide (30:70%). Following tracheostomy, the lungs were mechanically ventilated by a rodent ventila tor. The brains were perfusion-fixed via the ascending aorta with an infusion of prewarmed (37°C) 4% formalde hyde solution, buffered to pH 7.35, preceded by a short saline rinse. The brains were embedded in paraffin and sectioned at 6 ILm. The sections were stained with celes tine blue and acid fuchsin (Auer et aI., 1984) . Neuronal damage was assessed by light microscopy (400x) by a person blinded to the treatment. Undamaged neurons that had a prominent nucleus and stained violet and the total number of neurons were counted in defined CAl areas; B. NELLGARD AND T. WIELDeH medial CAl (Sl), mid-CAl (S2), and at the border to CA3 (S3) (Fig. lA) at a coronal level -3.8-4.0 mm caudal to bregma, and in two areas. T1 and T2 (Fig. lB) , of the dorsal temporal CAl area of hippocampus at a level 5.8 mm caudal to bregma (Paxinos and Watson, 1982) . Each examined area of CAl was 400 fLm. The neuronal damage was estimated in two consecutive sections in both hemi spheres, and neuronal necrosis was expressed as percent age damaged neurons of the total neuronal population. Neocortical damage was assessed in neocortex by light microscopy (lOOx) in a circular area with a diameter of 2 mm with its perimeter immediately dorsal to the entorhi nal fissure, -5.8 mm caudal to bregma.
The animals of this study were divided into five groups receiving the following: NBQX (lithium salt; n = 7), 30 mg kg-I (3 mg ml-I), was given intraperitoneally directly postischemia, followed by an intravenous infusion of 75 fLg min -I for 6 h. Control ischemic animals for the NBQX-treated group (control group A; n = 8) received lithium chloride (LiCl) 4.5 mg kg-I as a bolus dose intra peritoneally followed by an infusion of 2.25 mg kg-I h-I for 6 h and saline in similar volume as the NBQX-treated animals. Dizocilpine (n = 10), 1 mg kg-I, was given twice intraperitoneally, directly post ischemia and 3 h later. COP 40116 (n = 7) was given directly post ischemia by an intraperitoneal injection of 5 mg kg -I. Control isch- emic animals for the dizocilpine-and COP 40116-treated groups (control group B; n = 9) received saline.
For the statistical analysis of differences between ex perimental groups, the Kruskal-Wallis test followed by the Mann-Whitney U test was used when differences in neuronal damage were assessed. Student's t test and anal ysis of variance with a post hoc Dunnett test were used for determining differences in physiological parameters among experimental groups.
RESULTS
Blood glucose, temperature, and MABP of the animals in the different experimental groups are shown in Table 1 . No significant difference in the measured variables was seen between the different experimental groups. The drug-treated animals re gained corneal reflexes later than the vehicle treated animals and were lethargic during the first hours post ischemia. This was more pronounced in the dizocilpine-and CGP 40 1 16-treated animals than in the NBQX-treated ones. Mortality in the dizocilpine group was 2/ 12, in the CGP 40 116 group 3/ 11, in the NBQX group 0/7, in control group A 0/8, and in control group B 1/ 10. Figure 2 shows the neuronal necrosis in CAl ar eas of the septal hippocampus in animals exposed to 10 min of 2-VO ischemia. Neuronal damage (% ± SD) in NBQX-treated animals was as follows: S 1, 45 ± 19%; S2, 38 ± 19%, S3, 29 ± 9%; correspond ing damage in control ischemic rats was 80 ± 16, 76 ± 19, and 72 ± 20%. In the dorsal temporal hippo campus (Fig. 3) , neuronal damage in NBQX-treated animals was 22 ± 12% (Tl) and 17 ± 5% (T2) com pared with corresponding values in control animals of 54 ± 24 and 55 ± 22%. In all investigated hip pocampal CAl areas, NBQX significantly de creased neuronal damage by 44-69% compared with corresponding areas of ischemic control ani mals (p < 0. 01 and p < 0.05, Mann-Whitney U test). In NBQX-treated animals, significantly less neuronal damage was found in septal hippocampus compared with temporal hippocampus (p < 0. 05 Mann-Whitney U test).
Effects of NBQX on neuronal damage
Neuronal damage in the neocortex was most prominent in layers III and IV, dorsal to the ento rhinal fissure. NBQX treatment significantly (p < 0. 0 1, Mann-Whitney U test) mitigated neuronal damage (an average of 6 necrotic neurons) in a de fined cortical area compared with control ischemic rats (47 necrotic neurons) (Fig. 4) .
Effects of dizocilpine and CGP 40116 on neuronal damage Figure 5 shows neuronal necrosis in the septal hippocampus in control ischemic animals and ani- In the defined area of neocortex, the mean num ber of necrotic neurons in the control ischemic rats was 63 and in the dizocilpine-and CGP 40 1 16-treated rats 57 and 58 necrotic neurons, respec tively. No significant difference could be noted be tween the experimental groups (Kruskal-Wallis and Mann-Whitney U test) (Fig. 7) .
DISCUSSION
In this investigation we have demonstrated that (a) NBQX, an AMPA receptor blocker, decreases neuronal damage in cerebral cortex following tran sient cerebral ischemia in the rat, while no marked (Fig. 1 B) following 10 min of severe tran sient ischemia. Each circle represents one ex perimental animal and the mean is indicated in the figure. The NBQX-treated rats (30 mg kg-1 i.p. at recirculation, combined with an infusion of 75 I1-g min -1 for 6 h) showed significantly less neuronal damage in T1 (22%) and T2 (17%) when compared with neuronal damage in con trol ischemic animals: 54% (T1) and 55% (T2) 
Neuronal necrosis in the septal hippocampal CA 1 re gion was examined in three areas, 51, 52, and 53 (Fig. 1A) , in rats exposed to 10 min of severe transient ischemia. They were treated with either dizocilpine (1 mg i.p. at recirculation and after 3 h), CGP 40116 (5 mg i.p. at recirculation), or sa line. The damage is presented as the mean percentage neu ronal cell necrosis ± 5D (of total neuronal population). The neuronal damage in dizocilpine-treated animals (81, 73%; 52, 72%; 53, 72%; hatched bars) or CGP 40116-treated rats (51, 67%; 52, 62%; 53, 62%; cross-hatched bars) cannot sig nificantly be discerned from that in control ischemic animals (51, 75%; 52, 72%; 53, 71%; open bars) (Kruskal-Wallis test). For abbreviation see the text. Neuronal damage in the dorsotemporal hippocampal CA l region was examined in two areas, T1 and T2 (Fig. 18) . The neuronal necrosis is presented as the mean percentage of damaged neurons ± SO (of the total neuronal population).
In dizocilpine-treated rats (1 mg kg-l Lp. at recirculation and after 3 h), neuronal damage in T1 and T2 (hatched bars) was 69 and 70%, respectively. The corresponding values in CGP 40116-treated animals (5 mg kg-l Lp. at recirculation) were 60 and 60% (cross-hatched bars), and damage in control ischemic rats was 59% (T1) and 60% (T2) glutamatergic nerve fibers to the hippocampus CAl region led to a partial neuronal protection following a period of transient cerebral ischemia implied that glutamate neurotransmission was important in the development of delayed neuronal damage in the hippocampus. Thus, lesions to the perforant path (Wieloch et aI., 1985) , transections of the Schaffer collaterals (Onodera et aI., 1986; Benveniste et aI., 1989) , and lesions of the entorhinal cortex per formed prior to a transient ischemic insult (Jj2ir gensen et aI., 1987) mitigate neuronal damage in the CAl region ipsilateral to the lesion. However, con flicting results prevail as to the identity of the glu tamate receptor subtype(s) mediating neuronal damage.
AMP A receptor blockade but not NMDA receptor blockade decreases neuronal damage
The importance of NMDA receptor antagonists in the development of ischemic brain damage has been thoroughly studied in different models of ce rebral ischemia. From the vast number of investi gations, it may be concluded that protection pro vided by NMDA antagonists is dependent on the type of ischemic insult studied. Thus, in models of permanent focal ischemia (where one or several ma jor cerebral arteries are permanently occluded), NMDA receptor blockers are generally beneficial (Albers et aI., 1989) . For example, the noncompet itive NMDA receptor antagonist dizocilpine, used in the present investigation, has repeatedly been shown to decrease infarct size in focal ischemia (Kochhar et al., 1988; Park et al., 1988) . In contrast, in models of transient cerebral ischemia where neck arteries have been transiently occluded for a period of 5-30 min, several investigations have shown a lack of protection by NMDA receptor antagonists. For example, following complete or near-complete arrest of cerebral circulation, postischemic dizo cilpine treatment in rats (Buchan et aI., 199 1; Nell gard et aI., 199 1), cats (Fleischer et aI., 1989) , dogs (Michenfelder et aI., 1989; Sterz et aI., 1989) , and monkeys (Lanier et ai, 1990) did not decrease neu ronal damage. Contrary to these results, some in vestigations have demonstrated that competitive or noncompetitive NMDA receptor antagonists pro tect the hippocampal CAl area against ischemic damage (Rod et aI., 1990; Swan and Meldrum, 1990) .
In the present investigation we confirm our early observation that dizocilpine does not decrease neu ronal damage when administered in the postisch emic phase (Nellgard et aI., 199 1) . We also demon strate that the competitive NMDA receptor antag onist CGP 40 116 does not decrease neuronal damage, although this compound passes the BBB (Fagg et aI., 1989) and rapidly inhibits cortical spreading depression when given intravenously (B. Nellgard and T. Wieloch, unpublished results). As the body and skull temperatures were kept at 37°C and the preischemic blood glucose levels at 5-9 mmol L -I , changes in these parameters cannot ac count for the lack of protection by dizocilpine or CGP 40 1 16. We have previously proposed that the density of ischemia may determine the efficiency of NMDA receptor antagonists. Following transient moderate (incomplete) ischemia, the NMDA recep tor antagonists may be. effective cerebroprotec tants, while following severe (complete) ischemia, such as employed in the present investigation, NMDA receptor blockade is not cerebroprotective (Westerberg et aI., 1988; Wieloch and Westerberg, 1989; Nellgard et aI., 199 1) .
Since lesions of the glutamatergic system protect the CAl neurons following transient cerebral isch emia, while NMDA receptor blockade is not effec tive in these models, other glutamate receptor sub types than NMDA receptors must be involved in the degenerative process. The advent of relatively selective AMPA receptor inhibitors that pass the BBB, such as NBQX, has made it possible to study the importance of these receptors in the postisch emic phase. An earlier investigation demonstrated a protective effect of NBQX against neuronal damage following transient ischemia in the gerbil. Thus, in female Mongolian gerbils exposed to 5 min of bilat eral carotid occlusion, NBQX (3 x 30 mg kg-I) given intraperitoneally postischemia significantly decreased neuronal damage in the hippocampal CAl area (Sheardown et aI., 1990) . In the present investigation, we confirm the protective effect of NBQX in the rat. In our experimental paradigm, damage decreased by 44-60% in the septal and by 59-69% in the temporal hippocampus, demonstrat ing that NBQX is cerebroprotective and that this effect is more pronounced in the temporal com pared with the septal hippocampus. This difference could be due to the lesser ischemic insult inflicted upon the temporal area (Smith et aI., 1984) . Simi larly, as was proposed for the NMDA receptor an tagonists, the protection by NBQX blockade may also be dependent on the severity of the ischemic insult. If this holds true, AMPA receptors seem to be important in the mechanism of ischemic brain damage following transient severe ischemia, while following moderate ischemia, NMDA and/or AMP A receptors may contribute to the degenera tive processes. If the ischemic insult is severe and prolonged, other and glutamate-independent mech anisms may dominate the degenerative processes, This could be the reason why in a recent investiga tion protection by lesions to glutamate afferents in the CAl region could not be demonstrated following an insult of 30-min 4-VO ischemia (Buchan and Pulsinelli, 1990) . Another important finding of the present investi gation is that protection by AMPA receptor block ade is not uniquely confined to the hippocampus. The observed decrease in neuronal damage in neo cortex suggests that AMPA receptors may contrib ute to ischemic brain damage in other brain regions. The intracellular events underlying the ameliora tive effect of AMP A receptor blockade on neuronal damage in models of transient severe ischemia can only be speculated upon. Normally AMPA recep tors mediate fast excitatory transmission in the brain, and the cellular effects of AMPA receptor activation have been attributed to the depolariza-tion of the plasma membrane, increasing sodium and potassium ion fluxes. By this mechanism post ischemic AMP A receptor stimulation can be envis aged to activate voltage-dependent ion channels and/or reverse the 3Na + /Ca 2 + antiporter (Choi, 1988) . The pathophysiological event coupled to these processes could be an increase in intracellular calcium ion concentration that may prove toxic to the neurons (Siesj6, 198 1; Siesj6 and Bengtsson, 1989) . Enhanced depolarization of the plasma mem brane by AMPA receptors can activate the NMDA receptor-coupled channel (in the presence of gluta mate), but since blockade of the NMDA receptor failed to mitigate neuronal damage, the contribution of the postischemic NMDA receptor-stimulated calcium influx may not be significant. This could be due to a down-regulation of the receptor following intraischemic exposure to low pH (Giffard et aI., 1990) or by protein phosphorylation (Mody et aI., 1988) . Membrane depolarization by AMPA recep tor stimulation may also activate voltage-dependent calcium channels (Mayer and Miller, 1990) . How ever, in the present model of cerebral ischemia, a blocker of the dihydropyridine-sensitive calcium channel isradipine was ineffective in preventing hip poca mpal damage (Ohta et aI., 199 1) . If sodium en tered the neurons in massive amounts, thereby re versing the 3Na + /Ca 2 + antiporter, an increased metabolism due to activation of the Na +, K + ATPase would be expected in vulnerable areas and cell swelling would be evident. However, neither neuronal hyperactivity (Buzsaki et aI., 1989) nor an increase in CMRg1 (Pulsinelli et aI., 1982; Kozuka et aI., 1989) or neuronal swelling (Kirino and Sano, 1984) has been observed in the rat hippocampal CAl region during delayed neuronal death.
The dose of NBQX employed in this investigation was sufficient to prevent delayed neuronal death, but did not render the animals unconscious and ap parently is too low to completely inhibit normal fast excitatory transmission. This suggests that the re ceptors on vulnerable neurons may have become more sensitive to AMPA-mediated neurotransmis sion and are selectively blocked by NBQX follow ing ischemia, while leaving normal neurotransmis sion unaffected. Such a change in the sensitivity to AMP A receptor stimulation could be due either to a modification of the characteristics of the AMP A re ceptor or to an enhanced intracellular response to AMPA receptor stimulation.
The AMPA receptor itself may become modified by ischemia, changing its ion conductivity and/or ion selectivity (Ogura et aI., 1990) . At least eight different AMPA receptor mRNAs have been iden tified as coding for different subunits of the receptor protein. Various combinations of these subunits form AMPA receptors with different electrophysi ological properties (Keinanen et aI., 1990; Sommer et aI., 1990; Hollmann et aI., 199 1) . It is possible that ischemia may change the postischemic expres sion of AMP A receptors, leading to changes in ion conductivity and selectivity (Hollmann et aI., 199 1) . Another possibility is that the ischemic insult mod ifies the AMPA receptor-coupled processes. Re cently it was demonstrated that the AMP A receptor and the metabotropic glutamate receptor, the tACPD receptor (Monaghan et aI., 1989; Watkins et aI. 1990) , may act in concert to release arachidonate in striatal cultured neurons (Dumuis et al., 1990) . The tACPD receptor is a G protein-coupled recep tor that is regulated by, among others, protein ki nase C in a feedback mechanism. Following tran sient ischemia protein kinase C is down-regulated (Cardell et aI., 1990; Wieloch et aI., 199 1) , and it is possible that the feedback inhibition of the metabo tropic receptor fails post ischemia, leading to an enhanced response to glutamate stimulation.
Finally, the recent investigations demonstrating a coupling of non-NMDA receptors to events not di rectly related to synaptic transmission, such as reg ulation of the expression of nerve growth factor and brain-derived neurotrophic factor (Zafra et al., 1990) , open the possibility that disturbances in AMP A receptor activation lead to post ischemic detrimental changes in gene expression.
CONCLUSION
We conclude that AMPA receptors significantly contribute to the postischemic development of de layed neuronal death in the cerebral cortex of the rat, and blockade of this receptor may be important in future therapeutic interventions against brain damage following stroke or transient ischemic events. The exact intracellular mechanisms whereby AMPA receptors contribute to cell dam age are not yet fully comprehended. We speculate that ischemia changes the sensitivity of the vulner able neurons to AMPA-mediated glutamate trans mission, by modifying the AMPA receptor proper ties or the control mechanisms of AMP A receptor coupled processes.
